Related Experiment Video
Updated: Apr 14, 2026

09:10
Mesenchymal Stem Cell Regulation of Macrophage Phagocytosis; Quantitation and Imaging
Published on: July 16, 2021
3.7K
Mesenchymal stem cells attenuated PLGA-induced inflammatory responses by inhibiting host DC maturation and function
Heng Zhu1, Fei Yang2, Bo Tang1
1Department of Cell Biology, Institute of Basic Medical Sciences, Taiping Road 27, Beijing 100850, PR China.
Biomaterials
|April 20, 2015
Summary
Mesenchymal stem cells (MSCs) can suppress the inflammatory response caused by poly lactic-co-glycolic acid (PLGA) scaffolds by modulating dendritic cells (DCs). This finding offers a new strategy for improving tissue repair using PLGA scaffolds.
Area of Science:
- Biomaterials Science
- Immunology
- Regenerative Medicine
Background:
- Poly lactic-co-glycolic acid (PLGA) scaffolds are widely used in tissue repair but often trigger significant inflammatory responses.
- Dendritic cells (DCs) play a crucial role in initiating immune responses, and PLGA can induce their maturation, potentially exacerbating inflammation.
Purpose of the Study:
- To investigate the modulatory effects of mesenchymal stem cells (MSCs) on PLGA-induced DCs (PLGA-DCs).
- To explore the potential of MSCs in mitigating PLGA-associated inflammation for improved tissue repair.
Main Methods:
- In vitro co-culture of mouse MSCs and PLGA-stimulated DCs.
- Analysis of DC maturation markers, cytokine expression, and T cell differentiation.
- In vivo studies using MSC-PLGA constructs in mice to assess DC maturation, immune cell populations, and inflammatory responses at the scaffold site.
Main Results:
- MSCs inhibited PLGA-DC maturation, dendrite formation, and pro-inflammatory factor expression.
- MSC-educated PLGA-DCs promoted Th2 and regulatory T cell differentiation while suppressing Th1 and Th17 cells.
- In vivo, MSCs reduced mature DC proportions, alleviated inflammation around PLGA scaffolds, and shifted immune cell balance towards anti-inflammatory profiles.
Conclusions:
- MSCs effectively suppress PLGA-induced DC maturation and immune responses both in vitro and in vivo.
- Targeting DCs with MSCs presents a novel therapeutic strategy to reduce inflammation and enhance the efficacy of PLGA scaffold-based tissue repair.
Related Concept Videos
Mesenchymal Stem Cells
6.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.1K
T Cell Types and Functions
3.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.5K

